Henry ScheinHSIC +1.47%80 PEG Ratio is 3.21 as of Jun. 28, 2026, which is 12% above its 10-year median of 2.87. GuruFocus rates HSIC with a GF Score™ of 80/100 and a GF Value™ of $83.62 (Fairly Valued). The stock has 8 warning signs investors should review. Among 48 Medical Distribution companies, Henry Schein ranks worse than 66.67% on this metric.
* The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
The historical rank and industry rank for Henry Schein's PEG Ratio or its related term are showing as below:
HSIC'
s PEG Ratio Range Over the Past 10 Years
Min: 1.38 Med: 2.87 Max: 60
Current: 3.21
During the past 13 years, Henry Schein's highest PEG Ratio was 60.00. The lowest was 1.38. And the median was 2.87.
HSIC's PEG Ratio is ranked worse than 66.67% of 48
companies
in the Medical Distribution industry
Industry Median: 1.87
vs HSIC: 3.21
Peter Lynch thinks a company with a P/E ratio equal to its growth rate is fairly valued.
Henry Schein (NAS:HSIC) PEG Ratio Explanation
To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the P/E ratio divided by the growth ratio. He thinks a company with a P/E ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a P/E of 20, instead of a company growing 10% a year with a P/E of 10.
Henry Schein PEG Ratio Related Terms
Henry Schein PEG Ratio Historical Data
* Premium members only.
The historical data trend for Henry Schein's PEG Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Distribution subindustry, Henry Schein's PEG Ratio, along with its competitors' market caps and PEG Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Henry Schein PEG Ratio vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Henry Schein's PEG Ratio distribution charts can be found below:
* The bar in red indicates where Henry Schein's PEG Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Note: The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
Henry Schein (HSIC) has a PEG Ratio of 3.21 as of Jun. 28, 2026. Price-earnings to growth ratio is the ratio of price-earnings to a company's earnings growth rate. View historical data on Henry Schein and its competitors. This is 12% above median its historical median of 2.87. Over the past decade, Henry Schein's PEG Ratio has ranged from 1.38 to 60.00. According to the industry distribution chart, Henry Schein ranks #32 out of 48 companies in the Medical Distribution industry, placing it in the top 66.7%.
Is Henry Schein's PEG Ratio too high?
Henry Schein's current PEG Ratio of 3.21 is 12% above median its 10-year median of 2.87. Over the past 10 years, this metric has ranged from a low of 1.38 to a high of 60.00. The Medical Distribution industry median PEG Ratio is 1.87. Henry Schein's value of 3.21 is 71.7% above this industry median. Based on the distribution chart, Henry Schein ranks #32 out of 48 companies in the Medical Distribution industry, which is below the industry midpoint. Overall, Henry Schein has a GF Score™ of 80/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Henry Schein's PEG Ratio compare to AHG and ACH?
According to the Medical Distribution industry distribution chart, Henry Schein ranks #32 out of 48 companies for PEG Ratio. This places Henry Schein in the lower half of its industry. The industry median PEG Ratio is 1.87. Henry Schein's value of 3.21 is 71.7% above this benchmark. Historically, Henry Schein's own PEG Ratio has ranged from 1.38 to 60.00 over the past decade. While the company's 10-year median is 2.87 vs. the industry median of 1.87, Henry Schein has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PEG Ratio for a Medical Distribution company?
The median PEG Ratio among Medical Distribution companies is 1.87, based on 48 companies in the industry. Companies in the top quartile (top 25%) have a PEG Ratio significantly above this median, while those in the bottom quartile fall well below. However, PEG Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Henry Schein's current PEG Ratio of 3.21 is 71.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PEG Ratio mean?
A high PEG Ratio can signal that a stock is expensive relative to its fundamentals. Price-earnings to growth ratio is the ratio of price-earnings to a company's earnings growth rate. View historical data on Henry Schein and its competitors. For the Medical Distribution industry, the median PEG Ratio is 1.87 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Henry Schein's current PEG Ratio is 3.21, which is 12% above median its own 10-year median of 2.87. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Henry Schein stock overvalued right now?
Based on GuruFocus' analysis, Henry Schein (HSIC) is currently considered Fairly Valued. The stock's GF Value™ is $83.62, compared to a current price of $85.06 — trading 1.7% above its estimated fair value. The current PEG Ratio is 3.21, which is 12% above median its 10-year median of 2.87 and 71.7% above the Medical Distribution industry median of 1.87. Henry Schein's overall GF Score™ is 80/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PEG Ratio calculated?
PEG Ratio is calculated from a company's financial statements. For Henry Schein (HSIC), the current PEG Ratio is 3.21 as of Jun. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Henry Schein (HSIC) Overvalued in 2026?
Based on GuruFocus' analysis, Henry Schein stock appears to be overvalued.
The current stock price of $85.06 is trading 1.7% above its estimated GF Value™ of $83.62.
GuruFocus considers Henry Schein to be Fairly Valued.
Key valuation signals for HSIC:
PEG Ratio: 3.21 (12% above median its 10-year median of 2.87)
GF Value™: $83.62 vs. price of $85.06 (1.7% above fair value)
Industry Position: 71.7% above the Medical Distribution median (#32 of 48)
No single metric tells the full story. See the HSIC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Henry Schein Inc is a solutions company for healthcare professionals. It offers healthcare equipment, products, and services to office-based dental and medical practitioners, as well as alternative sites of care. The company's reportable segments are: Global Distribution and Value-Added Services, Global Specialty Products, and Global Technology. It generates maximum revenue from the Global Distribution and Value-Added Services segment, which includes distribution to the dental and medical markets of national brand and corporate brand merchandise, as well as equipment and related technical services. This segment also includes value-added services such as financial services, continuing education services, consulting, and other practice services.
80GF Score
Get the complete analysis for HSIC
PEG Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HSIC has been successfully added to your 
